chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 70.0
Sex: M
Vaccine: COVID19-2
Symptoms: Cough, Dyspnoea, Immunoglobulin therapy, Intensive care, Lung opacity
Clinical narrative: Hematologist/Oncologist: MD  Primary Care Physician at Discharge: MD Admission Date: 7/10/2023 Discharge Date: 07/17/2023  DETAILS OF HOSPITAL STAY: PRESENTING PROBLEM: Community acquired pneumonia of both lungs [J18.9] Acute respiratory failure [J96.00] Respiratory failure [J96.90]   HOSPITAL COURSE: This is a 70 y.o. patient with a past medical history significant for non-hodgkin's lymphoma, HTN, CAD, and HLD who presented to Hospital ER on 7/7 with symptoms of chills, fevers, cough and SOB. Pt reports contracting COVID in early June while on vacation. However his most recent COVID antigen test was negative. He felt he never fully recovered. He began having fevers and chills again on June 30 and presented to ER on 7/7 when his symptoms weren't improving. CTA of the thorax showed no PE but did show bilateral opacities. He was admitted to Hospital with bilateral CAP and treated with azithromycin and Rocephin until his transfer to different hospital for ID and pulmonology consults.  He did receive IVIG at Hospital prior to transfer.   Submitted ID and Pulmonary medicine was consulted and a bronchoscopy was performed on 07/11.  All workup was negative except for on the bronchoscopy did show that patient was COVID positive.  Unfortunately after the bronch on 07/11 patient had an episode of acute hypoxic respiratory failure and a RAP was called.  He was transferred to the intensive care unit and BiPAP was started.  Infectious disease recommended 5 days of remdesivir and steroids.  He was able to transfer out of the intensive care unit on 07/14.  He was very quickly weaned off of oxygen.  Initially pulmonary recommended a very long, approximately 8 week prednisone taper.  However the malignant heme attending was concerned about 18 for that long affecting his immune status.  I did reach out to Pulmonary Medicine on 07/17 to discuss shorter taper.  They were okay with an approximately 2 week taper.  Patient received his last dose of remdesivir and he was stable for discharge.  Above follow-up with Dr. was arranged.  He was discharged home in stable condition
Age: 70.0
Sex: M
Vaccine: COVID19-2
Symptoms: Pneumonia, Positive airway pressure therapy, Pyrexia, Respiratory failure, SARS-CoV-2 test negative
Clinical narrative: Hematologist/Oncologist: MD  Primary Care Physician at Discharge: MD Admission Date: 7/10/2023 Discharge Date: 07/17/2023  DETAILS OF HOSPITAL STAY: PRESENTING PROBLEM: Community acquired pneumonia of both lungs [J18.9] Acute respiratory failure [J96.00] Respiratory failure [J96.90]   HOSPITAL COURSE: This is a 70 y.o. patient with a past medical history significant for non-hodgkin's lymphoma, HTN, CAD, and HLD who presented to Hospital ER on 7/7 with symptoms of chills, fevers, cough and SOB. Pt reports contracting COVID in early June while on vacation. However his most recent COVID antigen test was negative. He felt he never fully recovered. He began having fevers and chills again on June 30 and presented to ER on 7/7 when his symptoms weren't improving. CTA of the thorax showed no PE but did show bilateral opacities. He was admitted to Hospital with bilateral CAP and treated with azithromycin and Rocephin until his transfer to different hospital for ID and pulmonology consults.  He did receive IVIG at Hospital prior to transfer.   Submitted ID and Pulmonary medicine was consulted and a bronchoscopy was performed on 07/11.  All workup was negative except for on the bronchoscopy did show that patient was COVID positive.  Unfortunately after the bronch on 07/11 patient had an episode of acute hypoxic respiratory failure and a RAP was called.  He was transferred to the intensive care unit and BiPAP was started.  Infectious disease recommended 5 days of remdesivir and steroids.  He was able to transfer out of the intensive care unit on 07/14.  He was very quickly weaned off of oxygen.  Initially pulmonary recommended a very long, approximately 8 week prednisone taper.  However the malignant heme attending was concerned about 18 for that long affecting his immune status.  I did reach out to Pulmonary Medicine on 07/17 to discuss shorter taper.  They were okay with an approximately 2 week taper.  Patient received his last dose of remdesivir and he was stable for discharge.  Above follow-up with Dr. was arranged.  He was discharged home in stable condition
Age: 40.0
Sex: F
Vaccine: COVID19
Symptoms: Blood test, Computerised tomogram, Electrocardiogram, Fatigue, Hypoaesthesia
Clinical narrative: Trigeminal neuralgia, tired,  nerve pain, facial numbness. Doctors have not found a reason or treatment. I?ve done MRI, bloodwork, X-rays, physical, EKG, CT scans. No resolution.
Age: 40.0
Sex: F
Vaccine: COVID19
Symptoms: Magnetic resonance imaging, Neuralgia, Trigeminal neuralgia, X-ray
Clinical narrative: Trigeminal neuralgia, tired,  nerve pain, facial numbness. Doctors have not found a reason or treatment. I?ve done MRI, bloodwork, X-rays, physical, EKG, CT scans. No resolution.
Age: 17.0
Sex: M
Vaccine: HEP
Symptoms: Wrong product administered
Clinical narrative: Patient was accidently given Heplisav B vaccine instead of Bexsero Vaccine.
Age: 69.0
Sex: F
Vaccine: VARZOS
Symptoms: Influenza like illness, Malaise, Pain in extremity
Clinical narrative: received shot monday. tuesday went to the park. started feeling ill. arm was hurting. pt went home and went to bed. was in bed most of the day. flu like symptoms achy no fever. wednesday  felt a little better but recently started feeling ill again. pt going home to go to bed again.
Age: 92.0
Sex: F
Vaccine: COVID19
Symptoms: Chills, Fatigue, Injection site pain
Clinical narrative: Painful arm at injection site and beyond. Chills and shivering Extreme fatigue
Age: 73.0
Sex: F
Vaccine: COVID19-2
Symptoms: Ammonia normal, Blood lactic acid normal, Bradycardia, COVID-19, Chest X-ray normal
Clinical narrative: BRIEF OVERVIEW: Admission Date: 7/22/2023 Discharge Date: Jul 24, 2023 Discharge Disposition:  home or self care  DETAILS OF HOSPITAL STAY: PRESENTING PROBLEM: Encephalopathy [G93.40] COVID-19 [U07.1]   HOSPITAL COURSE: Patient is a 73-year-old female with PMH significant hypertension, anxiety disorder, depression, ADHD, alcohol use disorder presents to the hospital on  7/22 with concerns for altered mental status.  Patient had developed symptoms including fever, cough, rhinorrhea, headache, sneezing, fatigue, diarrhea and myalgias about 6 days prior to presentation.  After testing positive for COVID-19, patient was started on Paxlovid on 07/22, of which she may have taken 1-2 doses.  Shortly thereafter, patient was noted to have progressive confusion and hence brought to the hospital. Patient was admitted, suspicion for Paxlovid related altered mental status.  CT head was negative for acute process, chest x-ray, urinalysis, ammonia, lactic acid were all reassuring.  Patient's mental status changes quickly improved, however persisted to have difficulty following commands, understanding information etc..  Out of abundance of caution, MRI brain was done to evaluate for stroke, however was negative. Her mental status changes were likely related to interaction between BuSpar and Paxlovid, with latter being a enzyme inhibitor, likely increased her available BuSpar in her system. She was discharged home on 07/24. Incidentally she was also noted to have asymptomatic bradycardia, EKG showing sinus bradycardia, with good chronotropic effect during daytime.  Bradycardia was mostly noted during nighttime.  Patient denied any lightheadedness or dizziness or syncope. She also has history of alcohol use disorder, quit drinking about 2 weeks prior to presentation, plans to stay quit.  She was given a 10 day course of thiamine. As far as COVID-19 infection, patient was significantly feeling better from her symptomatology, she is nearly 7 days after her symptoms had started, needs no further isolation.  Per her request, BuSpar dose was changed to 15 mg twice daily (patient was supposed to be on 30 mg twice daily, however is only taking 30 mg once daily.  I suggested to take 15 mg twice daily instead).  Adderall was discontinued-she no longer takes it.
Age: 73.0
Sex: F
Vaccine: COVID19-2
Symptoms: Computerised tomogram head normal, Confusional state, Cough, Diarrhoea, Electrocardiogram abnormal
Clinical narrative: BRIEF OVERVIEW: Admission Date: 7/22/2023 Discharge Date: Jul 24, 2023 Discharge Disposition:  home or self care  DETAILS OF HOSPITAL STAY: PRESENTING PROBLEM: Encephalopathy [G93.40] COVID-19 [U07.1]   HOSPITAL COURSE: Patient is a 73-year-old female with PMH significant hypertension, anxiety disorder, depression, ADHD, alcohol use disorder presents to the hospital on  7/22 with concerns for altered mental status.  Patient had developed symptoms including fever, cough, rhinorrhea, headache, sneezing, fatigue, diarrhea and myalgias about 6 days prior to presentation.  After testing positive for COVID-19, patient was started on Paxlovid on 07/22, of which she may have taken 1-2 doses.  Shortly thereafter, patient was noted to have progressive confusion and hence brought to the hospital. Patient was admitted, suspicion for Paxlovid related altered mental status.  CT head was negative for acute process, chest x-ray, urinalysis, ammonia, lactic acid were all reassuring.  Patient's mental status changes quickly improved, however persisted to have difficulty following commands, understanding information etc..  Out of abundance of caution, MRI brain was done to evaluate for stroke, however was negative. Her mental status changes were likely related to interaction between BuSpar and Paxlovid, with latter being a enzyme inhibitor, likely increased her available BuSpar in her system. She was discharged home on 07/24. Incidentally she was also noted to have asymptomatic bradycardia, EKG showing sinus bradycardia, with good chronotropic effect during daytime.  Bradycardia was mostly noted during nighttime.  Patient denied any lightheadedness or dizziness or syncope. She also has history of alcohol use disorder, quit drinking about 2 weeks prior to presentation, plans to stay quit.  She was given a 10 day course of thiamine. As far as COVID-19 infection, patient was significantly feeling better from her symptomatology, she is nearly 7 days after her symptoms had started, needs no further isolation.  Per her request, BuSpar dose was changed to 15 mg twice daily (patient was supposed to be on 30 mg twice daily, however is only taking 30 mg once daily.  I suggested to take 15 mg twice daily instead).  Adderall was discontinued-she no longer takes it.
Age: 73.0
Sex: F
Vaccine: COVID19-2
Symptoms: Encephalopathy, Fatigue, Headache, Magnetic resonance imaging head normal, Mental status changes
Clinical narrative: BRIEF OVERVIEW: Admission Date: 7/22/2023 Discharge Date: Jul 24, 2023 Discharge Disposition:  home or self care  DETAILS OF HOSPITAL STAY: PRESENTING PROBLEM: Encephalopathy [G93.40] COVID-19 [U07.1]   HOSPITAL COURSE: Patient is a 73-year-old female with PMH significant hypertension, anxiety disorder, depression, ADHD, alcohol use disorder presents to the hospital on  7/22 with concerns for altered mental status.  Patient had developed symptoms including fever, cough, rhinorrhea, headache, sneezing, fatigue, diarrhea and myalgias about 6 days prior to presentation.  After testing positive for COVID-19, patient was started on Paxlovid on 07/22, of which she may have taken 1-2 doses.  Shortly thereafter, patient was noted to have progressive confusion and hence brought to the hospital. Patient was admitted, suspicion for Paxlovid related altered mental status.  CT head was negative for acute process, chest x-ray, urinalysis, ammonia, lactic acid were all reassuring.  Patient's mental status changes quickly improved, however persisted to have difficulty following commands, understanding information etc..  Out of abundance of caution, MRI brain was done to evaluate for stroke, however was negative. Her mental status changes were likely related to interaction between BuSpar and Paxlovid, with latter being a enzyme inhibitor, likely increased her available BuSpar in her system. She was discharged home on 07/24. Incidentally she was also noted to have asymptomatic bradycardia, EKG showing sinus bradycardia, with good chronotropic effect during daytime.  Bradycardia was mostly noted during nighttime.  Patient denied any lightheadedness or dizziness or syncope. She also has history of alcohol use disorder, quit drinking about 2 weeks prior to presentation, plans to stay quit.  She was given a 10 day course of thiamine. As far as COVID-19 infection, patient was significantly feeling better from her symptomatology, she is nearly 7 days after her symptoms had started, needs no further isolation.  Per her request, BuSpar dose was changed to 15 mg twice daily (patient was supposed to be on 30 mg twice daily, however is only taking 30 mg once daily.  I suggested to take 15 mg twice daily instead).  Adderall was discontinued-she no longer takes it.
Age: 73.0
Sex: F
Vaccine: COVID19-2
Symptoms: Myalgia, Pyrexia, Rhinorrhoea, SARS-CoV-2 test positive, Sinus bradycardia
Clinical narrative: BRIEF OVERVIEW: Admission Date: 7/22/2023 Discharge Date: Jul 24, 2023 Discharge Disposition:  home or self care  DETAILS OF HOSPITAL STAY: PRESENTING PROBLEM: Encephalopathy [G93.40] COVID-19 [U07.1]   HOSPITAL COURSE: Patient is a 73-year-old female with PMH significant hypertension, anxiety disorder, depression, ADHD, alcohol use disorder presents to the hospital on  7/22 with concerns for altered mental status.  Patient had developed symptoms including fever, cough, rhinorrhea, headache, sneezing, fatigue, diarrhea and myalgias about 6 days prior to presentation.  After testing positive for COVID-19, patient was started on Paxlovid on 07/22, of which she may have taken 1-2 doses.  Shortly thereafter, patient was noted to have progressive confusion and hence brought to the hospital. Patient was admitted, suspicion for Paxlovid related altered mental status.  CT head was negative for acute process, chest x-ray, urinalysis, ammonia, lactic acid were all reassuring.  Patient's mental status changes quickly improved, however persisted to have difficulty following commands, understanding information etc..  Out of abundance of caution, MRI brain was done to evaluate for stroke, however was negative. Her mental status changes were likely related to interaction between BuSpar and Paxlovid, with latter being a enzyme inhibitor, likely increased her available BuSpar in her system. She was discharged home on 07/24. Incidentally she was also noted to have asymptomatic bradycardia, EKG showing sinus bradycardia, with good chronotropic effect during daytime.  Bradycardia was mostly noted during nighttime.  Patient denied any lightheadedness or dizziness or syncope. She also has history of alcohol use disorder, quit drinking about 2 weeks prior to presentation, plans to stay quit.  She was given a 10 day course of thiamine. As far as COVID-19 infection, patient was significantly feeling better from her symptomatology, she is nearly 7 days after her symptoms had started, needs no further isolation.  Per her request, BuSpar dose was changed to 15 mg twice daily (patient was supposed to be on 30 mg twice daily, however is only taking 30 mg once daily.  I suggested to take 15 mg twice daily instead).  Adderall was discontinued-she no longer takes it.
Age: 73.0
Sex: F
Vaccine: COVID19-2
Symptoms: Sneezing, Urine analysis normal
Clinical narrative: BRIEF OVERVIEW: Admission Date: 7/22/2023 Discharge Date: Jul 24, 2023 Discharge Disposition:  home or self care  DETAILS OF HOSPITAL STAY: PRESENTING PROBLEM: Encephalopathy [G93.40] COVID-19 [U07.1]   HOSPITAL COURSE: Patient is a 73-year-old female with PMH significant hypertension, anxiety disorder, depression, ADHD, alcohol use disorder presents to the hospital on  7/22 with concerns for altered mental status.  Patient had developed symptoms including fever, cough, rhinorrhea, headache, sneezing, fatigue, diarrhea and myalgias about 6 days prior to presentation.  After testing positive for COVID-19, patient was started on Paxlovid on 07/22, of which she may have taken 1-2 doses.  Shortly thereafter, patient was noted to have progressive confusion and hence brought to the hospital. Patient was admitted, suspicion for Paxlovid related altered mental status.  CT head was negative for acute process, chest x-ray, urinalysis, ammonia, lactic acid were all reassuring.  Patient's mental status changes quickly improved, however persisted to have difficulty following commands, understanding information etc..  Out of abundance of caution, MRI brain was done to evaluate for stroke, however was negative. Her mental status changes were likely related to interaction between BuSpar and Paxlovid, with latter being a enzyme inhibitor, likely increased her available BuSpar in her system. She was discharged home on 07/24. Incidentally she was also noted to have asymptomatic bradycardia, EKG showing sinus bradycardia, with good chronotropic effect during daytime.  Bradycardia was mostly noted during nighttime.  Patient denied any lightheadedness or dizziness or syncope. She also has history of alcohol use disorder, quit drinking about 2 weeks prior to presentation, plans to stay quit.  She was given a 10 day course of thiamine. As far as COVID-19 infection, patient was significantly feeling better from her symptomatology, she is nearly 7 days after her symptoms had started, needs no further isolation.  Per her request, BuSpar dose was changed to 15 mg twice daily (patient was supposed to be on 30 mg twice daily, however is only taking 30 mg once daily.  I suggested to take 15 mg twice daily instead).  Adderall was discontinued-she no longer takes it.
Age: 0.17
Sex: F
Vaccine: FLU4
Symptoms: Product administered to patient of inappropriate age
Clinical narrative: 2 month old given 6 month old flu vaccine
Age: 77.0
Sex: F
Vaccine: COVID19-2
Symptoms: Acute respiratory failure, Biopsy urethra abnormal, COVID-19 pneumonia, Computerised tomogram abdomen abnormal, Hepatic mass
Clinical narrative: came to the hospital due to acute hypoxemic respiratory failure in the setting of COVID-19 pneumonia.  Patient underwent several tests including CT abdomen and pelvis showing multiple liver masses secondary to metastases and omental carcinomatosis.  Patient underwent evaluation by Hematology-Oncology, in which patient underwent biopsy in which showed urothelial carcinoma.  Discussion was held with Hematology-Oncology and recommendation was for hospice services since patient is unable to tolerate any chemotherapy.  Family in agreement.  Patient will be discharged today under hospice services.
Age: 77.0
Sex: F
Vaccine: COVID19-2
Symptoms: Metastasis, Metastatic neoplasm, Transitional cell carcinoma urethra
Clinical narrative: came to the hospital due to acute hypoxemic respiratory failure in the setting of COVID-19 pneumonia.  Patient underwent several tests including CT abdomen and pelvis showing multiple liver masses secondary to metastases and omental carcinomatosis.  Patient underwent evaluation by Hematology-Oncology, in which patient underwent biopsy in which showed urothelial carcinoma.  Discussion was held with Hematology-Oncology and recommendation was for hospice services since patient is unable to tolerate any chemotherapy.  Family in agreement.  Patient will be discharged today under hospice services.
Age: 62.0
Sex: M
Vaccine: COVID19-2
Symptoms: Atrial flutter, Back pain, Balance disorder, Benign prostatic hyperplasia, Blood pressure increased
Clinical narrative: BRIEF OVERVIEW: Discharge Provider: , MD Primary Care Provider at Discharge:  DO Admission Date: 7/20/2023 Discharge Date: 7/22/203   DISCHARGE DIAGNOSES 1. COVID 2. L1 compression fracture 3. Mild hyponatremia 4. Chronic obstructive pulmonary disease 5. BPH 6. Chronic atrial flutter 7. Chronic diastolic congestive heart failure 8. Obstructive sleep apnea 9. Depression 10. Dyslipidemia 11. Essential hypertension 12. Sick sinus syndrome 13. Coronary artery disease  DETAILS OF HOSPITAL STAY: HOSPITAL COURSE: Patient is a 63 y.o. male who presented on 7/20 with cough, congestion and fatigue for 3 days, initially hypoxic to 88% with ambulation, found to be COVID+. Admitted for treatment. Patient also had a recent fall, and CT showed acute compression fracture at L1. Back pain controlled with tylenol and motrin. Patient's COVID symptoms improved with decadron for 3 doses, satting well on room air.  Upon discharge patient's back pain is improved.  Of note patient's blood pressure was elevated in the hospital.  Should be monitored by PCP and Cardiology outpatient.  Discharge with out-patient PT referral due to recent falls and balance deficits.    Prescribed 3 day course Decadron 6 mg on discharge, start taking 7/23, total steroid treatment will be 6 days.
Age: 62.0
Sex: M
Vaccine: COVID19-2
Symptoms: COVID-19, Cardiac failure congestive, Chronic left ventricular failure, Chronic obstructive pulmonary disease, Computerised tomogram abnormal
Clinical narrative: BRIEF OVERVIEW: Discharge Provider: , MD Primary Care Provider at Discharge:  DO Admission Date: 7/20/2023 Discharge Date: 7/22/203   DISCHARGE DIAGNOSES 1. COVID 2. L1 compression fracture 3. Mild hyponatremia 4. Chronic obstructive pulmonary disease 5. BPH 6. Chronic atrial flutter 7. Chronic diastolic congestive heart failure 8. Obstructive sleep apnea 9. Depression 10. Dyslipidemia 11. Essential hypertension 12. Sick sinus syndrome 13. Coronary artery disease  DETAILS OF HOSPITAL STAY: HOSPITAL COURSE: Patient is a 63 y.o. male who presented on 7/20 with cough, congestion and fatigue for 3 days, initially hypoxic to 88% with ambulation, found to be COVID+. Admitted for treatment. Patient also had a recent fall, and CT showed acute compression fracture at L1. Back pain controlled with tylenol and motrin. Patient's COVID symptoms improved with decadron for 3 doses, satting well on room air.  Upon discharge patient's back pain is improved.  Of note patient's blood pressure was elevated in the hospital.  Should be monitored by PCP and Cardiology outpatient.  Discharge with out-patient PT referral due to recent falls and balance deficits.    Prescribed 3 day course Decadron 6 mg on discharge, start taking 7/23, total steroid treatment will be 6 days.
Age: 62.0
Sex: M
Vaccine: COVID19-2
Symptoms: Computerised tomogram spine, Condition aggravated, Coronary artery disease, Cough, Depression
Clinical narrative: BRIEF OVERVIEW: Discharge Provider: , MD Primary Care Provider at Discharge:  DO Admission Date: 7/20/2023 Discharge Date: 7/22/203   DISCHARGE DIAGNOSES 1. COVID 2. L1 compression fracture 3. Mild hyponatremia 4. Chronic obstructive pulmonary disease 5. BPH 6. Chronic atrial flutter 7. Chronic diastolic congestive heart failure 8. Obstructive sleep apnea 9. Depression 10. Dyslipidemia 11. Essential hypertension 12. Sick sinus syndrome 13. Coronary artery disease  DETAILS OF HOSPITAL STAY: HOSPITAL COURSE: Patient is a 63 y.o. male who presented on 7/20 with cough, congestion and fatigue for 3 days, initially hypoxic to 88% with ambulation, found to be COVID+. Admitted for treatment. Patient also had a recent fall, and CT showed acute compression fracture at L1. Back pain controlled with tylenol and motrin. Patient's COVID symptoms improved with decadron for 3 doses, satting well on room air.  Upon discharge patient's back pain is improved.  Of note patient's blood pressure was elevated in the hospital.  Should be monitored by PCP and Cardiology outpatient.  Discharge with out-patient PT referral due to recent falls and balance deficits.    Prescribed 3 day course Decadron 6 mg on discharge, start taking 7/23, total steroid treatment will be 6 days.
Age: 62.0
Sex: M
Vaccine: COVID19-2
Symptoms: Dyslipidaemia, Essential hypertension, Fall, Fatigue, Hyponatraemia
Clinical narrative: BRIEF OVERVIEW: Discharge Provider: , MD Primary Care Provider at Discharge:  DO Admission Date: 7/20/2023 Discharge Date: 7/22/203   DISCHARGE DIAGNOSES 1. COVID 2. L1 compression fracture 3. Mild hyponatremia 4. Chronic obstructive pulmonary disease 5. BPH 6. Chronic atrial flutter 7. Chronic diastolic congestive heart failure 8. Obstructive sleep apnea 9. Depression 10. Dyslipidemia 11. Essential hypertension 12. Sick sinus syndrome 13. Coronary artery disease  DETAILS OF HOSPITAL STAY: HOSPITAL COURSE: Patient is a 63 y.o. male who presented on 7/20 with cough, congestion and fatigue for 3 days, initially hypoxic to 88% with ambulation, found to be COVID+. Admitted for treatment. Patient also had a recent fall, and CT showed acute compression fracture at L1. Back pain controlled with tylenol and motrin. Patient's COVID symptoms improved with decadron for 3 doses, satting well on room air.  Upon discharge patient's back pain is improved.  Of note patient's blood pressure was elevated in the hospital.  Should be monitored by PCP and Cardiology outpatient.  Discharge with out-patient PT referral due to recent falls and balance deficits.    Prescribed 3 day course Decadron 6 mg on discharge, start taking 7/23, total steroid treatment will be 6 days.
Age: 62.0
Sex: M
Vaccine: COVID19-2
Symptoms: Hypoxia, Malaise, Obstructive sleep apnoea syndrome, Respiratory tract congestion, SARS-CoV-2 test positive
Clinical narrative: BRIEF OVERVIEW: Discharge Provider: , MD Primary Care Provider at Discharge:  DO Admission Date: 7/20/2023 Discharge Date: 7/22/203   DISCHARGE DIAGNOSES 1. COVID 2. L1 compression fracture 3. Mild hyponatremia 4. Chronic obstructive pulmonary disease 5. BPH 6. Chronic atrial flutter 7. Chronic diastolic congestive heart failure 8. Obstructive sleep apnea 9. Depression 10. Dyslipidemia 11. Essential hypertension 12. Sick sinus syndrome 13. Coronary artery disease  DETAILS OF HOSPITAL STAY: HOSPITAL COURSE: Patient is a 63 y.o. male who presented on 7/20 with cough, congestion and fatigue for 3 days, initially hypoxic to 88% with ambulation, found to be COVID+. Admitted for treatment. Patient also had a recent fall, and CT showed acute compression fracture at L1. Back pain controlled with tylenol and motrin. Patient's COVID symptoms improved with decadron for 3 doses, satting well on room air.  Upon discharge patient's back pain is improved.  Of note patient's blood pressure was elevated in the hospital.  Should be monitored by PCP and Cardiology outpatient.  Discharge with out-patient PT referral due to recent falls and balance deficits.    Prescribed 3 day course Decadron 6 mg on discharge, start taking 7/23, total steroid treatment will be 6 days.
Age: 62.0
Sex: M
Vaccine: COVID19-2
Symptoms: Sinus node dysfunction, Spinal compression fracture
Clinical narrative: BRIEF OVERVIEW: Discharge Provider: , MD Primary Care Provider at Discharge:  DO Admission Date: 7/20/2023 Discharge Date: 7/22/203   DISCHARGE DIAGNOSES 1. COVID 2. L1 compression fracture 3. Mild hyponatremia 4. Chronic obstructive pulmonary disease 5. BPH 6. Chronic atrial flutter 7. Chronic diastolic congestive heart failure 8. Obstructive sleep apnea 9. Depression 10. Dyslipidemia 11. Essential hypertension 12. Sick sinus syndrome 13. Coronary artery disease  DETAILS OF HOSPITAL STAY: HOSPITAL COURSE: Patient is a 63 y.o. male who presented on 7/20 with cough, congestion and fatigue for 3 days, initially hypoxic to 88% with ambulation, found to be COVID+. Admitted for treatment. Patient also had a recent fall, and CT showed acute compression fracture at L1. Back pain controlled with tylenol and motrin. Patient's COVID symptoms improved with decadron for 3 doses, satting well on room air.  Upon discharge patient's back pain is improved.  Of note patient's blood pressure was elevated in the hospital.  Should be monitored by PCP and Cardiology outpatient.  Discharge with out-patient PT referral due to recent falls and balance deficits.    Prescribed 3 day course Decadron 6 mg on discharge, start taking 7/23, total steroid treatment will be 6 days.
Age: 14.0
Sex: M
Vaccine: HEPA, MMR, MNQ
Symptoms: Dizziness, Nausea
Clinical narrative: Patient received 3 vaccines. Patient began to feel faint and nauseated. Nursing provided water, ice pack to pt, and snack. Patient lied on cot and observed for 30min. Patient felt better, left with parent after being instructed to notify M.D if further discomfort noted. Call EMS for severe adverse reactions.
Age: 88.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Asthenia, Oedema peripheral
Clinical narrative: 2/22/2021- Moderna 030L20A  2/22/2021-Moderna 013M20A 90 years old woman who came with generalized weakness, bilateral lower extremity edema.  The patient has been having pitting lower extremity edema.  She was sent to the ER for worsening refractory lower extremity edema.   Continue with IV Decadron 6 mg IV daily Oxygen supplementation as needed
Sex: M
Vaccine: COVID19-2, UNK
Symptoms: Acute respiratory failure, COVID-19 pneumonia, Leukocytosis, Pneumonia bacterial, Sepsis
Clinical narrative: Acute hypoxic respiratory failure requiring O2 therapy, resolved COVID-19 Pneumonia, improving  Sepsis without Shock due to above, improving  Leukocytosis, improving - SpO2 goal > 88% - currently off supplemental oxygen with good oxygen saturation  - DC Remdesivir d/t LFTs in the 1K - C/w Dexa 6 mg daily x 10 days - C/w Rocephin for suspected underlying bacterial PNA
Age: 92.0
Sex: M
Vaccine: COVID19-2, FLU4
Symptoms: Adult failure to thrive, Asthenia, COVID-19, Chest X-ray abnormal, Computerised tomogram head normal
Clinical narrative: BRIEF OVERVIEW: Discharge Provider: MD Primary Care Provider at Discharge: MD  Admission Date: 7/20/2023 Discharge Date: 7/22/2023 DETAILS OF HOSPITAL STAY: PRESENTING PROBLEM: Weakness [R53.1] Generalized weakness [R53.1] Failure to thrive in adult [R62.7] COVID-19 virus detected [U07.1]   HOSPITAL COURSE: Patient presented to the emergency department on 7/20/23 with complaint of weakness and fall at home. He was also utilizing his PRN oxygen more than normal.    In the ER vital signs were stable with appropriate oxygen saturations on room air.  Initial labs showed relatively unremarkable CMP, hemoglobin 12.9.  He tested positive for COVID-19 in the ER.  A UA was negative.  A CT head was negative for acute intracranial hemorrhage.  Chest x-ray showed chronic coarse lung markings but otherwise no acute findings. X-ray of the lumbar spine showed severe compression fracture at T9 which was progressed from 11/18/2022.  Patient received a total of 1 L normal saline in the ER and was admitted to the hospitalist service for further management of weakness, COVID-19, and T9 compression fracture. For the compression fracture at T9, case was discussed with Dr. of Ortho Spine and he recommended no further intervention or brace at this time and out patient follow up as needed.    During hospitalization, he remained on room air. PT/OT recommended SAR due to continued weakness and risk for fall. Unfortunately, patient was unwilling to go to COVID appropriate SAR facility due to distance from home.   Remainder of chronic medical conditions remained stable.    Today, he was in bed during examination. Please see today's progress note for examination and further information.   Patient has opted for discharge home with home PT/OT which was arranged by care management. Family and patient understand risks due to his continued generalized weakness which includes additional falls. Please see discharge instructions for further information.
Age: 92.0
Sex: M
Vaccine: COVID19-2, FLU4
Symptoms: Condition aggravated, Fall, Haemoglobin, Lung disorder, SARS-CoV-2 test positive
Clinical narrative: BRIEF OVERVIEW: Discharge Provider: MD Primary Care Provider at Discharge: MD  Admission Date: 7/20/2023 Discharge Date: 7/22/2023 DETAILS OF HOSPITAL STAY: PRESENTING PROBLEM: Weakness [R53.1] Generalized weakness [R53.1] Failure to thrive in adult [R62.7] COVID-19 virus detected [U07.1]   HOSPITAL COURSE: Patient presented to the emergency department on 7/20/23 with complaint of weakness and fall at home. He was also utilizing his PRN oxygen more than normal.    In the ER vital signs were stable with appropriate oxygen saturations on room air.  Initial labs showed relatively unremarkable CMP, hemoglobin 12.9.  He tested positive for COVID-19 in the ER.  A UA was negative.  A CT head was negative for acute intracranial hemorrhage.  Chest x-ray showed chronic coarse lung markings but otherwise no acute findings. X-ray of the lumbar spine showed severe compression fracture at T9 which was progressed from 11/18/2022.  Patient received a total of 1 L normal saline in the ER and was admitted to the hospitalist service for further management of weakness, COVID-19, and T9 compression fracture. For the compression fracture at T9, case was discussed with Dr. of Ortho Spine and he recommended no further intervention or brace at this time and out patient follow up as needed.    During hospitalization, he remained on room air. PT/OT recommended SAR due to continued weakness and risk for fall. Unfortunately, patient was unwilling to go to COVID appropriate SAR facility due to distance from home.   Remainder of chronic medical conditions remained stable.    Today, he was in bed during examination. Please see today's progress note for examination and further information.   Patient has opted for discharge home with home PT/OT which was arranged by care management. Family and patient understand risks due to his continued generalized weakness which includes additional falls. Please see discharge instructions for further information.
Age: 92.0
Sex: M
Vaccine: COVID19-2, FLU4
Symptoms: Spinal X-ray abnormal, Spinal compression fracture, Thoracic vertebral fracture, Urine analysis normal
Clinical narrative: BRIEF OVERVIEW: Discharge Provider: MD Primary Care Provider at Discharge: MD  Admission Date: 7/20/2023 Discharge Date: 7/22/2023 DETAILS OF HOSPITAL STAY: PRESENTING PROBLEM: Weakness [R53.1] Generalized weakness [R53.1] Failure to thrive in adult [R62.7] COVID-19 virus detected [U07.1]   HOSPITAL COURSE: Patient presented to the emergency department on 7/20/23 with complaint of weakness and fall at home. He was also utilizing his PRN oxygen more than normal.    In the ER vital signs were stable with appropriate oxygen saturations on room air.  Initial labs showed relatively unremarkable CMP, hemoglobin 12.9.  He tested positive for COVID-19 in the ER.  A UA was negative.  A CT head was negative for acute intracranial hemorrhage.  Chest x-ray showed chronic coarse lung markings but otherwise no acute findings. X-ray of the lumbar spine showed severe compression fracture at T9 which was progressed from 11/18/2022.  Patient received a total of 1 L normal saline in the ER and was admitted to the hospitalist service for further management of weakness, COVID-19, and T9 compression fracture. For the compression fracture at T9, case was discussed with Dr. of Ortho Spine and he recommended no further intervention or brace at this time and out patient follow up as needed.    During hospitalization, he remained on room air. PT/OT recommended SAR due to continued weakness and risk for fall. Unfortunately, patient was unwilling to go to COVID appropriate SAR facility due to distance from home.   Remainder of chronic medical conditions remained stable.    Today, he was in bed during examination. Please see today's progress note for examination and further information.   Patient has opted for discharge home with home PT/OT which was arranged by care management. Family and patient understand risks due to his continued generalized weakness which includes additional falls. Please see discharge instructions for further information.
Age: 86.0
Sex: F
Vaccine: COVID19-2, FLUA4
Symptoms: Asthenia, COVID-19
Clinical narrative: Discharge Provider: MD Primary Care Provider at Discharge: MD Admission Date: 7/18/2023 Discharge Date: 7/28/2023   DETAILS OF HOSPITAL STAY: PRESENTING PROBLEM: Weakness [R53.1]   Patient is a 87 y.o. female with past medical history significant for hypertension, hyperlipidemia, possible chronic obstructive pulmonary disease presented to the emergency department by family for generalized weakness post recent COVID19 infection.  Patient did not have any major acute issues or findings in workup.  She was seen by PT/OT who recommended SAR; she was discharged to SAR on 7/28.
Age: 4.0
Sex: F
Vaccine: DTAP
Symptoms: Injection site erythema, Injection site swelling
Clinical narrative: Redness and swelling at injection site.
Age: 62.0
Sex: F
Vaccine: COVID19-2
Symptoms: Dizziness, Vertigo, Vomiting
Clinical narrative: I woke up the morning after receiving the vaccine very dizzy. The vertigo persisted for 2 days so far. At one point, the vertigo caused me to throw up.
Age: 70.0
Sex: F
Vaccine: RSV
Symptoms: Injection site erythema, Injection site inflammation, Injection site nodule, Injection site pain, Product administered at inappropriate site
Clinical narrative: Patient came back to the pharmacy today and showed an injection site reaction where the skin was red, inflamed, knotted, and sore where the injection was placed. The injection site looked to be lower and more towards the back of the arm instead of into the deltoid muscle. Patient has been monitoring and utilizing warm compresses for relief.
Age: 53.0
Sex: M
Vaccine: COVID19-2, FLU4, TDAP
Symptoms: Arthralgia, C-reactive protein, Differential white blood cell count, Full blood count, Musculoskeletal pain
Clinical narrative: Starting an hour or so after the injection I started experiencing soreness in my left arm. This progressively got worse over the next few days with left side neck pain, pain around my left shoulder and shoulder blade, and pain down my left arm.  The pain got bad to the point that I could not get comfortable or sleep. OTC remedies, heat and cold had minor effect providing minor and temporary relief.  On November 3rd after little to no resolution of the pain, I sought help at facility. This has continued to today.  It is still unresolved.
Age: 53.0
Sex: M
Vaccine: COVID19-2, FLU4, TDAP
Symptoms: Neck pain, Pain in extremity, Red blood cell sedimentation rate, Sleep disorder, X-ray
Clinical narrative: Starting an hour or so after the injection I started experiencing soreness in my left arm. This progressively got worse over the next few days with left side neck pain, pain around my left shoulder and shoulder blade, and pain down my left arm.  The pain got bad to the point that I could not get comfortable or sleep. OTC remedies, heat and cold had minor effect providing minor and temporary relief.  On November 3rd after little to no resolution of the pain, I sought help at facility. This has continued to today.  It is still unresolved.
Age: 56.0
Sex: F
Vaccine: COVID19
Symptoms: Gingival disorder, Gingival pain, Gingival swelling, Groin pain, Oral discomfort
Clinical narrative: I received the Comirnaty vaccine. When I woke up the next morning, I experienced (and continue to experience) pain in my lower front gums, across the base of my lower teeth. There is redness and a few white bumps on the gums and a red spot on the inside of my lower lip. It feels swollen and bruised - very painful to the touch and just pain in general. My mouth is burning a little.  My dentist checked everything out, and there is no reason this should be happening - no tooth infections or nerve infections. Just swollen gums. It hurts!
Age: 35.0
Sex: M
Vaccine: COVID19
Symptoms: Asthenia, Full blood count, Malaise, Metabolic function test, Syncope
Clinical narrative: syncope. He was not feeling well, went to the bathroom and felt weak and syncope
Age: 0.67
Sex: F
Vaccine: COVID19
Symptoms: Incorrect dose administered, Product preparation error
Clinical narrative: Vaccine was not diluted before giving vaccination
Age: 69.0
Sex: F
Vaccine: COVID19-2
Symptoms: Fall
Clinical narrative: Patient fell approx 2 hours post vaccination.
Age: 81.0
Sex: M
Vaccine: COVID19
Symptoms: Wrong product administered
Clinical narrative: no symptoms, patient came in and stated he needed covid and rsv but only wanted rsv today, the processing technician misuderstood which shot he wanted and we administered covid today
Age: 24.0
Sex: M
Vaccine: ANTH, FLU4, TYP, YF
Symptoms: Abdominal pain, Anaphylactic reaction, Dysphonia, Fatigue, Headache
Clinical narrative: 30 S/P Administration of deployment vaccination patient began to feel lethargy, fatigue, HA, Mild vague abdominal pain, hoarseness, and diffuse trunk hive like rash. Transfers via POV to nearby clinic where monitor shows HOTN, Mild Hypoxia which continued to worsen which prompted Epi Pen Admin x1 at 0.3. EMS was consulted and he was transferred to ED where he was put under further observations and discharged 2 hours later. Dx w/ Anaphylaxis due to Vaccine, though unsure which one.
Age: 24.0
Sex: M
Vaccine: ANTH, FLU4, TYP, YF
Symptoms: Hypoxia, Lethargy, Rash, Urticaria
Clinical narrative: 30 S/P Administration of deployment vaccination patient began to feel lethargy, fatigue, HA, Mild vague abdominal pain, hoarseness, and diffuse trunk hive like rash. Transfers via POV to nearby clinic where monitor shows HOTN, Mild Hypoxia which continued to worsen which prompted Epi Pen Admin x1 at 0.3. EMS was consulted and he was transferred to ED where he was put under further observations and discharged 2 hours later. Dx w/ Anaphylaxis due to Vaccine, though unsure which one.
Age: 82.0
Sex: M
Vaccine: COVID19
Symptoms: Blood glucose normal, Dizziness
Clinical narrative: pt came in after his covid vaccine stating he was feeling dizzy and light headed. I had him sit down and got some vitals on him BP 158/82 p-78 o2-96 I had him lay down for a while and gave him some water. after about 15 minutes I went back in the room and asked him how he was feeling. pt stated he was feeling a bit better than when he came in. I asked when the last time he ate anything, he stated he ate around 1pm. I got the lab to run BS and it came back at 132.  I had him sit up for another 10-15 minutes. I consulted AH and she told me to have him sit and keep observing him and also report to VAERS. after 15 minutes I went back in, pt stated he was still feeling better and i took his vitals again BP-146/78 p-63 o2-95. I told the pt to stay seated for a little while longer and he agreed. this time. pt stated that he does keep track of his BP and the readings we were getting seems to be  bit higher. i asked him if he was on BP medication and he stated that he was and he did take it today. He stayed seated for 5-10 more minutes and i took his BP 150/78 he stted that he felt better not 100% but well enough to get home. i advised if he didnt feel well he did not have to go, he stated he felt well enough. i advised pt to call the office if he had any further questions or concerns, i also advised to go to UC or ER if he started to feel dizzy and light headed again. pt verbalized understanding.
Age: 0.33
Sex: F
Vaccine: FLU4
Symptoms: Product administered to patient of inappropriate age
Clinical narrative: Fluarix vaccine given to a child 4 months old
Age: 45.0
Sex: F
Vaccine: FLU4
Symptoms: Arthralgia, C-reactive protein increased, CSF test normal, Joint swelling, Paraesthesia
Clinical narrative: Sudden onset severe joint pain and swelling, lower extremity paresthesias. Lasted over 2 weeks. Required lumbar puncture to rule out Guillan Barre syndrome. Improved slowly overtime with prednisone.
Age: 38.0
Sex: M
Vaccine: COVID19, FLUA4
Symptoms: Incorrect dose administered, Product administered to patient of inappropriate age
Clinical narrative: Nurse gave Pfizer2023/2024 5-11yo vaccination and a FluQuad (65+yo) vaccination to a 38 year old patient. Nurse pulled vaccines from the incorrect stock and failed to perform rights of drug administration in a rush.  The Clinic Manager found this error during inventory count and immediately notified the Chief Operations Officer and Chief Clinical Officer of the facility.  The patient has not reported any adverse affects.  Patient is being notified by the Chief Medical Officer.  The nurse has been given a verbal warning and reeducation and extra training has been put in place.  Additional signage of  rights of drug administration have been posted in the vaccination area as well as rooms.
Age: 32.0
Sex: M
Vaccine: HEP
Symptoms: Hyperhidrosis, Loss of consciousness
Clinical narrative: AFTER RECEIVEING THE HEPLISAV-B VACCINE PT WENT TO THE FRONT DESK TO SCHEDULE FOR HIS SECOND DOSE. AT THAT TIME THE PATIENT CONFIRMED HIS NEXT APPOINTMENT AND THEN SLOWLY WENT DOWN TO THE FLOOR AND PASSED OUT FOR A BRIEF SECOND. TWO OF OUR MALE EMPLOYEES AND OCC HEALTH NURSE ASSISTED PATIENT IN GETTING TO A CHAIR. PATIENTS LEGS WERE ELEVATED AT THAT TIME, COLD PACK WAS GIVEN TO PATIENT AS HE WAS NOTICABLY SWEATING, VITALS WERE TAKE AND ALL WITHIN RANGE. PATIENT WAS MONITORED FOR 20 MINUTES BEFORE PATIENT FELT OKAY TO LEAVE.
Age: 11.0
Sex: M
Vaccine: HPV9
Symptoms: Extra dose administered
Clinical narrative: Patient received extra dose of HPV vaccine. Patient had already received two doses:  1st dose: 9/20/2021 (9 y.o) 2nd dose: 11/1/2022 (10 y.o)
Age: 84.0
Sex: F
Vaccine: FLU4
Symptoms: Injection site pain, Muscular weakness, Musculoskeletal disorder
Clinical narrative: Patient states pain at injection site as well as weakness and loss of function in the left arm.
Age: 13.0
Sex: M
Vaccine: HPV9
Symptoms: Injection site oedema, Loss of personal independence in daily activities, Mass, Pain, Swelling
Clinical narrative: swelling,mass lump  pain interfering with activities referred to orthopedic and physical therapy
Age: 13.0
Sex: M
Vaccine: HPV9
Symptoms: Ultrasound scan abnormal
Clinical narrative: swelling,mass lump  pain interfering with activities referred to orthopedic and physical therapy
Age: 60.0
Sex: M
Vaccine: VARZOS
Symptoms: Lymphadenopathy, Swelling
Clinical narrative: SWELLING IN LYMPH NODES IN MID TO LATE JUNE.  SEVERE SWELLING LASTING THROUGH AUGUST.   SWELLING STILL BUT NOT AS MUCH AT TIME OF REPORTING
Age: 10.0
Sex: M
Vaccine: COVID19
Symptoms: Incorrect dose administered, No adverse event, Product label issue
Clinical narrative: Patient given 0.5 mL from single dose vial. Informed later that the vial is labeled for single dose but must instead be taken for only 0.25 mL as advised for patient age group. Patient remained at baseline and did not require further treatment.
Age: 64.0
Sex: F
Vaccine: TDAP
Symptoms: Antinuclear antibody, Autoantibody test, C-reactive protein, Injection site discomfort, Red blood cell sedimentation rate increased
Clinical narrative: Upper right arm discomfort upon palpation and upon extension, especially at inner and back of upper right arm. Patient also reports "lumpy" sensation.
Age: 64.0
Sex: F
Vaccine: TDAP
Symptoms: Sensory disturbance
Clinical narrative: Upper right arm discomfort upon palpation and upon extension, especially at inner and back of upper right arm. Patient also reports "lumpy" sensation.
Age: 73.0
Sex: F
Vaccine: RSV
Symptoms: Abdominal pain upper, Decreased appetite, Dizziness, Ear pain, Fatigue
Clinical narrative: Dizzy immediately after vaccine.  That night, slight fever, fatigue, headache, and sore muscles on left side of neck.  Next day fever went up to 100.5 at night,  fatigue, stomach ache, loss of appetite, ear ache, headache.  Drinking lots of water and herbal tea.  Eating mostly soup and fresh fruit.  Taking Tylenol PM tablet to sleep, both nights. Bed rest and sleeping during the afternoon 1-2  hours.  Today, two days after vaccine, feeling better.  Still tired, still eating bland food and  soup and tea.  Slight nausea.  Temp dropped to 97.8 degrees in am.
Age: 73.0
Sex: F
Vaccine: RSV
Symptoms: Headache, Immediate post-injection reaction, Myalgia, Nausea, Pyrexia
Clinical narrative: Dizzy immediately after vaccine.  That night, slight fever, fatigue, headache, and sore muscles on left side of neck.  Next day fever went up to 100.5 at night,  fatigue, stomach ache, loss of appetite, ear ache, headache.  Drinking lots of water and herbal tea.  Eating mostly soup and fresh fruit.  Taking Tylenol PM tablet to sleep, both nights. Bed rest and sleeping during the afternoon 1-2  hours.  Today, two days after vaccine, feeling better.  Still tired, still eating bland food and  soup and tea.  Slight nausea.  Temp dropped to 97.8 degrees in am.